A New Era for Ribavirin Aerosols to Treat Respiratory Syncitial Virus Infections in Immunocompromised Patients?
Université François Rabelais CEPR / INSERM UMR1100 Department of Pulmonology CHU de Tours Tours, France diot@med.univ-tours.fr.
Patrice
P
Diot
Université François Rabelais CEPR / INSERM UMR1100 Department of Pulmonology CHU de Tours Tours, France.
Laurent
L
Plantier
D000336:Aerosols; D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D012136:Respiratory Syncytial Viruses; D012254:Ribavirin / Q000627:therapeutic use*
D000336:Aerosols; D000998:Antiviral Agents; D012254:Ribavirin